2Thase ME. Effectiveness of antidepressants:comparative remission rates.J Clin Psychiatry,2003,64(Suppl,2) :3-7.
3Keck PE, McElroy SL. New approaches in managing bipolar depression.J Clin Psychiatry,2003,64 (Suppl, 1): 13-18.
4Lam RW, Kennedy SH. Evidence-based strategies for achieving and sustaining full remission in depressiong focus on Metaanalyses. Can J Psychiatry ,2004,49 (Suppl, 1): 17-26.
5MacQueen G, Chokka P. Speciel issues in the management of depression in women. Can J Psychiatry,2004,49 (Suppl, 1) :27-40.
6Charney DS. Psychobiological mechanisms of resilience and vulnerability:implications for successful adaptation to extreme stress. Am J Psychiatry,2004,161:195-216.
7Kjernisted KD, Bleau P. Long-term goals in the management of acute and chronic anxiety disorders. Can J Psychiatry,2004,49( Suppl, 1 ) :51-63.
9Simon JS, Aguiar LM, Kunz NR, et al. Extended release venlafaxine in relapse prevention for patients with major depressive disorder. J Psychiat Res, 2004,38: 249-257.
10Argyropoulos SV, Bell C J, Nutt DJ. Brain function in social anxiety disorder. Psychiat Clin North Am,2001,24(4) :707-721.
7Bauer M, Bschor T, Pfenning A, et al. World Federation of societies of biological psychiatry (WFSBP) guidelines for biological treat- ment of unipolar depressive disorders in primary care[ J ]. World J Biol Psychiatry ,2007,8,67-104.
8Rachid F, Bertschy G. Safety and efficacy of repetitive transcranial magnetic stimulation in the treatment of depression:a critical ap- praisal of the last 10 years[ J]. Neurophysiology Clinique, 2006, 36 : 157-183.
9Marangell LB, Martinez M, Jurdi RA, et al. Neurostimulation thera- pies in depression:a review of new modalities [ J ]. Acta Psychiatr, Scand,2007,116 : 174-181.
10Zanardini R, Gazzoli A, Ventriglia M, et al. Efect of repetitive tran- ranial magnetic stimulation on semm brain derived neurotmphic fac- tor in drug resistant depressed patients [ J ]. J Afect Disord,2006, 91:83-86.
